22 Nov 2018 | 12:31 AM
 

Marksans Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524404 | NSE Symbol: MARKSANS
29.35
0.25
(0.86 %)
21 Nov 2018 | 04:01 PM
Change company
  • Open (Rs)
    28.95
  • Prev. close (Rs.)
    29.10
  • High (Rs.)
    29.70
  • Low (Rs.)
    28.80
  • 52W H (Rs.)
    50.25
  • 52W L (Rs.)
    23.55
  • Volume
    119651
  • MCap (Rs in Cr.)
    1,201.34
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
0.87
Operating Margin (%)
9.47
Gross Profit Margin (%)
6.53
Net Profit Margin (%)
3.92
Total Debt/Equity
0.25
Dividend payout Ratio (Net Profit)
6.88
Earning Retention Ratio
93.12

News

30 May 2018 - 14:20:00-The company reported standalone net profit of Rs 4...
13 Nov 2017 - 12:57:00-The company reported standalone net profit of Rs 1...
09 Oct 2017 - 15:57:00-Drug firm Marksans Pharma today said it has received Establishment Inspection Report (EIR) from the ...
11 Aug 2017 - 14:57:00-The company reported standalone net profit of Rs 1...

Announcements

20-Nov-2018
Marksans Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
20-Nov-2018
Marksans Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
13-Nov-2018
Marksans Pharma - Unaudited Financial Results For The Quarter Ended 30Th September 2018 And Limited Review Reports Thereon.
13-Nov-2018
Marksans Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
13-Nov-2018
Marksans Pharma - Outcome of Board Meeting

Religare Research

21 Nov 2018 | 02:52 PM
Srikalahasthi Pipes Ltd (SPL) registered strong revenue growth of 28.6% YoY in Q2FY19, largely drive...
21 Nov 2018 | 12:49 PM
VIP Industries (VIP) reported healthy set of numbers for Q2FY19 with a revenue and PAT growth of 29....
21 Nov 2018 | 12:35 PM
Wim plast ltd (WPL) reported subdued numbers for Q2FY19, which were below our expectation. Its reven...
21 Nov 2018 | 10:25 AM
DTF

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
6,68,725 6.05 22.13 0.19
6,68,725 6.05 36.06 0.18
6,68,725 6.05 38.52 0.18
6,68,725 6.05 25.64 0.19

Shareholding Pattern

       
Promotors48.25%
Mutual Funds/UTI0.00%
FI/Banks1.58%
Insurance1.58%
FII2.98%
Government0.00%
Others7.45%

Peer Group

Company Intraday Graph
 Hester Biosciences Ltd.
1,111.00(-2.17)
3572
 DIL Ltd.
950.00(-1.74)
3299
 TTK Healthcare Ltd.
775.55(-0.25)
3392
 Kovai Medical Center and Hospital Ltd.
698.00(-0.11)
11816

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Marksans Pharma Ltd.0.60-3.603.10
NIFTY(S&P CNX)354.80-951.7083.35
BSE SENSEX1,065.42-3,078.95583.67
BSE 500570.73-1,432.31-275.53

Corporate Details

Key Personal
Mark Saldanha
Chairman & Managing Director
Sandra Saldanha
Whole Time Director
Vinay Gopal Nayak
Whole Time Director
Key Address
Registered Office
11th Floor Grandeur Veera Desai Extension Road Oshiwara Andheri (West),Mumbai,Maharashtra

Tel:022-40012000, Fax:022-40012011

companysecretary@marksanspharma.com
http://www.marksanspharma.com
Registrar Office
Bigshare Services Pvt. Ltd.
Add. :4E/8 1st Floor Jhandewalan Extension